Currently, glucocorticoids, antibiotics, neutralizing antibodies (such as anti-IL-6), and stem cell-based therapies are mainly employed in clinics to calm the CRS and treat CRS-induced pneumonia [9,10,11]. The gene discussed is IL6; the disease is congenital rubella syndrome.